Acusphere, Inc.
Adams, Harkness & Hill
Advanced Technology Ventures
Adveg
Advent International
Agencourt Bioscience Corp
Alantos Pharmaceuticals, Inc.
American Stock Exchange
Ampersand Ventures
AnorMED Inc.
Apax Partners, Inc.
Arakis Ltd
Ascension Health Ventures
AstraZeneca Pharmaceuticals
Atlas Venture
atugen AG
Aureon Biosciences Corporation
Avecia Biotechnology Inc
Bank of America
Basel Area
Battelle Ventures, LP
Bedford Research Foundation
BELS
Beth Israel Deaconess Medical Center
Beyond Genomics, Inc.
BIDMC
BIOCORTECH
BioEnterprise Asia
BioExec Ventures LLC
Bio-ITWorld
Bioscience Managers Ltd
Biota, Inc.
BioTeam Paris Region
Biotech Consortium India Limited
BioVeda Capital
BioVex Limited
Boeringer Ingelheim GmbH
Bookbinder Capital Management LLC
Boston Millennia Partners
Boston University
Boston University Venture Capital
Brandeis University
Brigham, Center for Neurological Disease
British Consulate-General
Bund Capital Ltd
Burrill & Company
Business Wire
c2venture, LLC
CalyxBio
Cambridge Associates LLC
Cardinal Partners
Carolina Securities Inc
Catalyst Health and Technology Partners
CB Health Ventures, L.L.C.
CDP Capital - Technology Ventures
Cellectis SA
Center for BioDynamics
China ChipScreen Biosciences
CHRONOGEN INC
Chronogen Inc.
Collinson Howe & Lennox
CombinatoRx, Inc.
Comerica Bank
Concurrent Pharmaceuticals, Inc.
ConjuGon Inc
Connecticut Innovations
CPP Advisors LLC
CRESA Partners
Crimson Pharmatech USA
Cubist Pharmaceutical
Curis, Inc
Cyclacel Ltd
Cytopia Pty Ltd
Deloitte & Touche LLP
DYN Diagnostics Holding Ltd
Early State Enterprises, LP
Ecopia BioSciences Inc.
Eidogen, Inc.
Elixir Pharmaceuticals
EntreMed, Inc.
Envivo Pharmaceutical
EPIX Medical, Inc.
Evergreen Investment Management
Evergreen Partners Ltd
Feinstein Kean Healthcare
Ferghana Partners
Fidelity Biosciences Group
Fidelity Investments
Fish & Richardson
Flagship Ventures
Focal Points
French Embassy Trade Office
Friedman Billings Ramsey
GE Life Science Finance
GeneExpress Inc
Generex Biotechnology Corporation
GenOdyssee
Genomics Collaborative
Genstruct, Inc.
Gentium S.p.A
Genzyme Corporation
GlaxoSmithKline
Global Genomics AB
Global Life Science Ventures
Global Markets Capital Corporation
Greylock Management Corporation
Grove Street Advisors
GSAS Harvard Biotechnology Club
Hambrecht & Quist Capital Management
HarbourVest Partners LLC
Harvard - MIT Biomedical Enterprise Program
Harvard Business School
Harvard Clinical Research Institute
Harvard Medical School, Division of Medical Sciences
Harvard School of Public Health
Harvard University
Harvard/MIT Biomedical Enterprise Program
Helsinn Healthcare SA
Henry Schafer Partners
HMS-MIT Biomedical Enterprise Program
HMS-MIT Biomedical Enterprise Program
Hub Angel Investment Group, LLC
Hudson Health Sciences
Hybrigenics
Immunitor USA Inc
Imperial College Innovations Ltd
Industrifonden
Infinity Pharmaceuticals
Innovation Path Inc.
Inproteo Inc
INSTITUT PASTEUR
International Finance Corporation
Investor Growth Capital, Inc.
IsoTis OrthoBiologics
John A. Levin & Co.
Johnson & Johnson
Johnson Graduate School of Management, Cornell
Kalypsys, Inc.
Katan Associates
KBL Healthcare Ventures
Ken Clark International
Kirkpatrick & Lockhart LLP
L.E.K Consulting
LaVoie Strategic Communications Group
Leerink Swann & Company
LifePoint Inc.
Lundbeck Inc
M.I.T Technology Licensing Office
MacroChem Corporation
Mancino Burfield Edgerton
Marine Polymer Technology
Mass High Tech
Massachusetts General Hospital
Massachusetts Institute of Technology
MDS Capital
MEDICA VENTURE PARTNERS
Medtrack
Memorial Sloan Kettering Cancer Center
Merck & Co., Inc.
Merck Research Laboratories
Mercury Therapuetics
Merger Market
Merrimack Pharmaceuticals
MethylGene, Inc.
Millennium Pharmaceuticals, Inc.
MIT
MIT Sloan School of Management
Monument Group
Moors & Cabot
MPM Capital
Munich Biotech AG
MVM Life Science Partners
MWG Biotech AG
Myomatrix Therapeutics
National Institutes of Health
Nature Biotechnology
Nature Publishing Group
NeuroMed Technologies Inc.
New England Partners
New Scientist
Newron Pharmaceuticals SpA
Nextech Venture
NGN Capital
NIB Capital Private Equity
NIF Ventures
Nomura
Norgen Biotek Corp.
Northeastern University, Program in Women's Studies
Northrop Grumman Information Technology
Novartis Institutes for Biomedical Research
Novartis Pharmaceuticals Corporation
Novation, Inc.
Novo A/S
Nuevolution A/S
Opexa Pharmaceuticals, Inc.
Oxford Bioscience Partners
Oxford Finance Corporation
Oxxon Pharmaccines Ltd
Palmer & Dodge LLP
Partners HealthCare
Perkins, Smith & Cohen, LLP
Perlan
Perseus-Soros Biopharmaceutical Fund, LP
Pfizer Global R&D
Pharmaceutical Executive
Phytopharm plc
Pioneer Investments
Polaris Venture Partners
Predix Pharmaceuticals
PureTech Ventures
Putnam Investments
Quorex Pharmaceuticals, Inc.
R&D focus/ DRUG NEWS
Radcliffe Consulting
RheoGene, Inc
Rockport Venture Partners
Ruston Poole International
Saturn Life Sciences
Schroder Ventures Life Sciences
Science
Seaflower Ventures
Serenex, Inc.
Serono
SG Cowen Securities Corporation
SHARE, Consulate of Switzerland
Sherris Pharma Partners
Silicon Valley Bank
Simon School of the Univeristy of Rochester
Skandia Liv Asset Management
Smith & Nephew
Sofinnova Partners
Sovereign Bank
Still River Funds
Stressgen Biotechnologies Corp.
Swifton Equity Advisors
Sycamore Ventures
Symbollon Pharmaceuticals, Inc.
Testa Hurwitz & Thibeault
The CBR Institute for Biomedical Research
The Children's Hospital, Dept. Of Genetics, Harvard Medical School
"The Henry M. Jackson Foundation
for the Advancement of Military Medicine, Inc."
The Ruth Group
The Scientist
The Vested Interest
Therion Biologics Corporation
Tienta Sciences Inc
Transave, Inc.
Trillium Medical Ventures, LLC
Trine Pharmaceuticals Inc
UBS Investment Bank
University of Cambridge
University of Pennsylvania
VascuLogic
Venture Capital Group
Vertex Pharmaceuticals Inc.
Viral Therapeutics, Inc.
Vital Science & Health / BioIT World Magazine
Whithead Institute
Womble Carlyle Sandridge & Rice PLLC 
Wyeth BioPharma
Wyeth Pharmaceuticals
XL TechGroup
YankeeTek Ventures
Zelos Therapeutics Inc.
Zero Stage Capital Company, Inc.
Zycos, Inc.